Sunshine Biopharma Warrant Stock Analysis
| SBFMW Stock | USD 0.17 0.04 19.05% |
Sunshine Biopharma Warrant is overvalued with Real Value of 0.14 and Hype Value of 0.17. The main objective of Sunshine Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what Sunshine Biopharma Warrant is worth, separate from its market price. There are two main types of Sunshine Biopharma's stock analysis: fundamental analysis and technical analysis.
The Sunshine Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Sunshine Biopharma is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Sunshine Stock trading window is adjusted to America/New York timezone.
Sunshine |
Sunshine Stock Analysis Notes
The company recorded a loss per share of 2.21. Sunshine Biopharma had not issued any dividends in recent years. Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada. Sunshine Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To find out more about Sunshine Biopharma Warrant contact the company at 954-515-0810 or learn more at https://sunshinebiopharma.com.Sunshine Biopharma Investment Alerts
| Sunshine Biopharma is way too risky over 90 days horizon | |
| Sunshine Biopharma has some characteristics of a very speculative penny stock | |
| Sunshine Biopharma appears to be risky and price may revert if volatility continues | |
| Sunshine Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 24.09 M. Net Loss for the year was (4.51 M) with profit before overhead, payroll, taxes, and interest of 110.6 K. | |
| Sunshine Biopharma Warrant has accumulated about 40.56 M in cash with (8.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sunshine Biopharma launches generic liver drug in Canada - Investing.com |
Sunshine Profitablity
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.17) | (0.18) | |
| Return On Capital Employed | (0.22) | (0.21) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.21) | (0.20) |
Management Efficiency
The company has return on total asset (ROA) of (0.1075) % which means that it has lost $0.1075 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1798) %, meaning that it generated substantial loss on money invested by shareholders. Sunshine Biopharma's management efficiency ratios could be used to measure how well Sunshine Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.18 in 2024. Return On Capital Employed is likely to climb to -0.21 in 2024. At this time, Sunshine Biopharma's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 26.1 M in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (1.7 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.7 K | 1.8 K | |
| Tangible Book Value Per Share | 1.6 K | 1.7 K | |
| Enterprise Value Over EBITDA | 2.36 | 2.48 | |
| Price Book Value Ratio | 0.31 | 0.30 | |
| Enterprise Value Multiple | 2.36 | 2.48 | |
| Price Fair Value | 0.31 | 0.30 |
Sunshine Biopharma has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Operating Margin (0.13) | Profit Margin (0.13) | Beta (1.04) | Return On Assets (0.11) | Return On Equity (0.18) |
Technical Drivers
As of the 1st of December, Sunshine Biopharma has the Semi Deviation of 14.8, coefficient of variation of 814.06, and Risk Adjusted Performance of 0.1035. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sunshine Biopharma, as well as the relationship between them. Please validate Sunshine Biopharma variance and potential upside to decide if Sunshine Biopharma is priced more or less accurately, providing market reflects its prevalent price of 0.17 per share. As Sunshine Biopharma appears to be a penny stock we also recommend to double-check its total risk alpha numbers.Sunshine Biopharma Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sunshine Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sunshine Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sunshine Biopharma Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sunshine Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sunshine Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sunshine Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Camille Sebaaly over a month ago Acquisition by Camille Sebaaly of 30000 shares of Sunshine Biopharma at 0.7635 subject to Rule 16b-3 | ||
Steve Slilaty over three months ago Acquisition by Steve Slilaty of 1100000 shares of Sunshine Biopharma at 0.001 subject to Rule 16b-3 | ||
Steve Slilaty over six months ago Acquisition by Steve Slilaty of 321305416 shares of Sunshine Biopharma at 0.0026 subject to Rule 16b-3 |
Sunshine Biopharma Predictive Daily Indicators
Sunshine Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sunshine Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sunshine Biopharma Forecast Models
Sunshine Biopharma's time-series forecasting models are one of many Sunshine Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sunshine Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Sunshine Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Sunshine Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sunshine shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sunshine Biopharma. By using and applying Sunshine Stock analysis, traders can create a robust methodology for identifying Sunshine entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.17) | (0.18) | |
| Operating Profit Margin | (0.20) | (0.21) | |
| Net Loss | (0.19) | (0.20) | |
| Gross Profit Margin | 0.35 | 0.36 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sunshine Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.